- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 10-08-2026: Press Release
10-08-2026 | 04:48 pm
10-08-2026 | 04:48 pm
Wockhardt reported strong Q1 FY27 results: PAT Rs. 107 Cr, revenue up 26% to Rs. 929 Cr, EBITDA up 86%. Biotech operations surged 112%. US FDA approved Zaynich for cUTI, a landmark for an India-discovered drug. Miqnaf® also launched in India.
No comments yet. Be the first to comment!